Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Anders Neijber
Person

Anders Neijber

Tracked across 2 events · 14 articles · First seen Jun 08, 2026 · Last active Aug 14, 2026

Sentiment
25
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
3 50
Business
Photocure, Artera partner bladder cancer AI
Impact: Anders Neijber, Chief Medical Officer of Photocure, provided commentary on the collaboration's objectives and potential benefits for bladder cancer management.
Jun 08, 2026 · 8 articles
4 0
Regulatory
FDA Proposes Reclassifying Blue Light Cystoscopy Systems
On August 14, 2026, the U.S. United States — Food and Drug Administration (FDA) published a proposed order in the Federal Register to reclassify cystoscopic systems intended as an aid for the detection of bladder…
Impact: Anders Neijber, Chief Medical Officer of Photocure, expressed support for the FDA's initiative, emphasizing the maturity of BLC technology.
Aug 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Anders Neijber live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.